INTRODUCTION
============

Compared to first-ever stroke, recurrent stroke is responsible for greater disability, with more-severe physical, psychological, and social impairments.[@B1] Previous community-based studies have revealed that 8--12% of stroke patients experience recurrence within 1 year after an initial stroke.[@B1][@B2][@B3] Risk factors for stroke recurrence include prior stroke, hypertension, heart failure, diabetes, hyperlipidemia, metabolic syndrome, and poor lifestyle,[@B4][@B5][@B6][@B7] and these factors have been extensively investigated for secondary stroke prevention. Stroke subtype, neuroimaging findings, and several blood markers are also well-recognized risk factors for recurrence, but these factors cannot be modified.[@B8][@B9]

While the current approach to secondary prevention primarily focuses on controlling these risk factors, there has been unsatisfactory progress in preventing recurrence. Functional status and rehabilitation are also recently identified factors that are significant for recurrence.[@B10][@B11] Functional status refers to the ability of an individual to perform the normal daily activities required to meet basic needs, fulfill usual roles, and maintain health and well-being.[@B12][@B13] Functional status subsumes related concepts of interest; functional capacity and functional performance.[@B12] While functional capacity represents the capacity of an individual to perform daily activities in the physical, psychological, social, and spiritual domains of life, functional performance refers to the activities that people actually participate in during the course of their daily lives.[@B12] Functional impairment means the loss of functional status, and it was used in the restricted sense of activity limitation in the present study.[@B14] For example, Park and Ovbiagele[@B11] reported stepwise relationships between increasing disability and risk of recurrent stroke that contrasted with the outcomes in patients with no disability. Impaired physical activity is a major risk factor for stroke occurrence, and exercise is recommended to prevent stroke and cardiovascular events.[@B15] In addition, early functional recovery after stroke can enable survivors to increase their active physical activity and thereby ultimately reduce the probability of stroke recurrence.

However, there has been little research into the potential associations of specific functional indicators with functional impairment and stroke recurrence. It is especially necessary to establish an appropriate rehabilitation strategy to prevent recurrence. Therefore, we conducted a prospective observational study of patients with noncardioembolic ischemic stroke (NCIS) to determine functional indicators that affect recurrence within the first year.

METHODS
=======

Patient selection
-----------------

This study was based on the Korean Stroke Cohort for Functioning and Rehabilitation (KOSCO) report.[@B16] The study protocols were approved by the ethics committee of each hospital. The study objectives, design, and risks/benefits were explained to the patients, and written informed consent was obtained upon hospitalization. The study protocols were approved by the ethics committee of each hospital (IRB No. WKUH-1515).

This study enrolled 882 first-ever NCIS patients transferred to a department of rehabilitation after being treated for acute stroke ([Fig. 1](#F1){ref-type="fig"}). Trial of Org 10,172 in Acute Stroke Treatment (TOAST) criteria were used to detect NCIS.[@B17] These ischemic stroke subtypes were determined by stroke neurologists at each participating hospital based on neuroimaging findings, medical history, and use of medication. The patients were discharged from the participating hospitals after undergoing inpatient rehabilitation for approximately 3 weeks. Patients who died (*n*=19) due to causes other than stroke recurrence or were lost to follow-up (*n*=76) during the 1-year analysis period were excluded. The causes of death of these patients were as follows: pneumonia (*n*=11), cardiac event (*n*=3), cancer (*n*=2), traffic accident (*n*=2), and liver cirrhosis (*n*=1). Among the 787 patients who completed follow-up, hemorrhagic (*n*=150) and cardioembolic ischemic stroke (*n*=69) patients were excluded. Therefore, 568 patients with NCIS were finally selected for this study.

Demographic and clinical assessments
------------------------------------

A complete data survey of all patients was conducted based on a review of medical records. Items including demographic data, cerebrovascular risk factors, and family/social history were surveyed using standardized, structured questionnaires. The National Institutes of Health Stroke Scale (NIHSS) was used to evaluate the severity of neurological deficits in the emergency room. Comorbidities were assessed using the Charlson Comorbidity Index (CCI), which contains 19 categories of comorbidity and predicts the mortality of patients who may have a range of comorbid conditions.[@B18][@B19][@B20] Because higher CCIs indicate greater comorbidities, we divided the patients into two groups based on a CCI of 2 points, and analyzed the risk of recurrence separately in these groups.[@B18] Laboratory data, stroke features, acute treatments, and medications commonly prescribed at discharge were assessed.

Functional status evaluation
----------------------------

Comprehensive face-to-face functional evaluations were performed at discharge. All evaluations were conducted by research assistants who were sufficiently trained and rigorously tested. The functional status in terms of the level of dependency, ambulation, motor function, activities of daily living, cognition, language ability, swallowing function, mood, and health-related quality of life were evaluated extensively at discharge after receiving stroke rehabilitation using the following standardized tools: modified Rankin Scale (mRS),[@B21] Functional Ambulation Category (FAC),[@B22] Fugl-Meyer Assessment (FMA),[@B23] Functional Independence Measure (FIM),[@B24] Korean version of the Mini Mental State Examination (K-MMSE),[@B25] Korean version of the Frenchay Aphasia Screening Test (K-FAST),[@B26] American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale (ASHA-NOMS),[@B27] Geriatric Depression Scale--Short Form (GDS-SF),[@B28] and EuroQoL-5 Dimensions (EQ-5D),[@B29] respectively ([Supplementary Table 1](#S1){ref-type="supplementary-material"} in the online-only Data Supplement).

Several functional indicators were analyzed after dichotomization according to the degree of dependence or severity in order to establish possible rehabilitation strategies in the future. For example, a mRS score of 3 or more indicates that the patient has moderate-to-severe functional impairment, and a FAC score of 3 or less means that the patient requires manual contact with another person during ambulation on level surfaces. The FMA motor score was divided into two groups according to the severity: mild (\>79) and moderate to severe (0--79).[@B23] The FIM ranges from 18 to 126 points and is a common tool used for assessing the ability to perform the activities of daily living.[@B24] These assessments were performed in the present study based on dividing the level of dependence on others into two groups: mild (\>90) and moderate to severe (18--90).[@B24] The K-MMSE score was analyzed by dividing the patients into two groups, with scores of 0--23 points indicating moderate-to-severe cognitive impairment and scores of more than 23 points indicating mild cognitive dysfunction.[@B25] The ASHA-NOMS scores were also analyzed by dividing patients into two groups corresponding to normal (7 points) and abnormal (≤6 points) swallowing function.

Identification of stroke recurrence within 1 year
-------------------------------------------------

Detailed information about stroke recurrence was collected at 3 months, 6 months, and 1 year after stroke onset. All patients were approached for follow-up assessments using a two-step approach.[@B16] We first regularly obtained follow-up information via telephone interviews with the patients themselves or their caregivers. All of the survivors were subsequently invited to visit the outpatient clinics of the hospitals where they were first admitted to complete a battery of functional assessments, structured self-administered questionnaires, and face-to-face interviews. If patients were not able to return for the follow-up assessments, research assistants visited the patients at their homes to perform these same evaluations. Stroke recurrence was confirmed based on the medical records of each participating hospital whenever the patients themselves or their caregivers reported recurrence during these follow-up initiatives.

Statistical analysis
--------------------

We used univariate Cox proportional-hazards regression to identify differences in baseline characteristics between patients with and without recurrence. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated using the univariate Cox proportional-hazards model. We also determined the risk of subsequent stroke recurrence in relation to each variable by using multivariate Cox proportional-hazards regression analysis. A backward conditional procedure was performed using *p*\>0.10 in the likelihood ratio test for exclusion. The regression model included the time to recurrent stroke as the response, and clinical/functional predictors of recurrence with a univariate probability value of *p*\<0.1 as an independent variable. Because sex and the initial NIHSS score measured in the emergency room are well-known factors involved in stroke recurrence,[@B30][@B31][@B32] these factors were additionally included and analyzed in the final model. The Kaplan-Meier method was used to evaluate the distribution of time to events according to the characteristics derived from the multivariate Cox proportional-hazards regression analysis. Intergroup comparisons were performed using the log-rank test. A probability value of *p*\<0.05 was considered significant. All analyses were performed using SPSS statistical software (version 22.0; IBM Corp., Armonk, NY, USA).

RESULTS
=======

This study analyzed 568 patients (age=65.1±17.4 years, mean±SD; 318 males and 250 females), of which 34 patients experienced recurrent stroke during the 1-year observation period, giving a recurrence rate following NCIS of 6.0% (34/568). Four patients died due to stroke recurrence. The period to discharge after stroke onset was 34.4±7.0 days, and we identified that NCIS was caused by large-artery atherosclerosis in 446 (79%) patients, small-vessel occlusion in 108 (19%) patients, and another cause in 14 (2%) patients.

Univariate analyses
-------------------

The clinical characteristics, laboratory data, stroke features, and medications prescribed at discharge are presented in [Table 1](#T1){ref-type="table"}. Age (HR=1.04, 95% CI=0.97--1.06, *p*=0.016), a CCI higher than 2 (HR=2.20, 95% CI=1.30--3.24, *p*=0.008), atrial fibrillation (HR=1.80, 95% CI=1.02--3.03, *p*=0.060), hyperlipidemia (HR=1.73, 95% CI=1.12--2.88, *p*=0.055), and large-artery atherosclerosis (HR=2.19, 95% CI=1.33--3.42, *p*=0.028) were significantly associated with stroke recurrence.

[Table 2](#T2){ref-type="table"} presents the results for the functional factors associated with the risk of stroke recurrence. The period to discharge after stroke onset was 34.8±6.8 days in the patients with recurrent stroke and 34.2±7.0 days in those who were recurrence-free during the 1-year analysis period. Significant associations with the risk of stroke recurrence were found for an mRS score of 3 or more (HR=1.85, 95% CI=1.28--2.54, *p*=0.010), an FAC score of 3 or less (HR=3.89, 95% CI=2.32--5.65, *p*\<0.001), and an FMA motor score of 79 or less (HR=1.46, 95% CI=1.02--1.90, *p*=0.048).

Multivariate analyses
---------------------

A subsequent analysis was performed of all significant variables after the univariate analyses. As indicated in [Table 3](#T3){ref-type="table"}, the independent predictors of stroke recurrence within 1 year after onset in the multivariate Cox proportional-hazards regression analysis were 1) patient age (per-year HR=1.04, 95% CI=0.97--1.06, *p*=0.048), 2) CCI higher than 2 (HR=1.72, 95% CI=1.26--2.22, *p*=0.016), 3) mRS score of 3 or more (HR=1.56, 95% CI=1.22--1.94, *p*=0.032), and 4) FAC score of 3 or less (HR=2.56, 95% CI=1.84--3.31, *p*=0.008). According to the Kaplan-Meier analysis, there were significant differences in recurrence-free survival between patients with mRS score ≥3 and mRS score \<3 at discharge (*p*=0.034, log-rank test), and between patients with FAC score ≤3 and FAC score \>3 at discharge (*p*=0.016, log-rank test) ([Fig. 2](#F2){ref-type="fig"}). In addition, the recurrence-free survival period was significantly shorter for patients with CCI \>2 than for those with CCI ≤2 (*p*=0.028, log-rank test).

DISCUSSION
==========

The present study found that functional impairment (especially ambulatory function) at discharge, age, and the severity of comorbidities were independent predictors of recurrence within 1 year after the onset of NCIS. The results of this study imply that applying other interventions to promote function---in addition to previously developed medical treatments for secondary stroke prevention---may reduce the probability of stroke recurrence.

The functional status based on the mRS score after simplification into two categories (no or slight functional impairment and moderate-to-severe functional impairment) was a strong indicator of recurrence. It was previously shown that functional impairment at approximately 1 month poststroke is related to long-term functional outcome,[@B21] and the present results are similar to those reported previously.[@B11][@B33] It was reported that compared to no/slight functional impairment (mRS score ≤2), moderate functional impairment (mRS score=3) after a recent NCIS was independently associated with an almost 1.5-fold higher risk of recurrent stroke within 2 years.[@B11] The mRS did not indicate impairment of any specific functional domains, since it is an index of the overall dependence according to the severity of gross functional impairment.[@B34] However, the previous study did not precisely consider what functional deficits were underlying these findings. Instead, reactive depression arising from clearly more-disabling consequences, and vitamin D deficiency due to limited mobility and decreased sunlight exposure were thought to be the factors underlying the low mRS scores and stroke recurrence.[@B11]

In contrast, our present comprehensive analysis of overall functional indicators has confirmed that ambulatory function is a critical factor for stroke recurrence. Those patients who needed help from others or were not able to walk at all (FAC score ≤3) were approximately 2.5-fold more likely to experience recurrence than those who did not have such deficits. The underlying mechanisms linking ambulatory function and stroke recurrence remain unclear, but they can be inferred from several reports. Kono et al.[@B35] reported that physical activity quantified based on the step count during ambulation was an independent predictor of the recurrence of vascular events (68% for stroke and 32% for coronary heart disease) in stroke survivors. It is widely known that lifestyle modifications for secondary stroke prevention significantly reduce the probability of stroke recurrence and other vascular events, and physical activity also tends to be associated with stroke recurrence.[@B7][@B36][@B37] Another study found that walking itself enhanced endogenous fibrinolysis by increasing tissue plasminogen activator and decreasing the activity of plasminogen activator inhibitor PAI-1 in stroke patients.[@B38] Moreover, Cheng et al.[@B10] discovered that rehabilitation during the first year after stroke was significantly associated with a lower incidence of recurrent stroke and all-cause mortality. Therefore, a rehabilitation strategy that focuses on the recovery of ambulatory function should be strongly considered to prevent recurrence.

Comorbidity was also a strong predisposing factor for recurrence in patients with NCIS. Although there has been little research into the relevance of comorbidities to stroke recurrence, a few possible mechanisms can be considered. It is known that the CCI is a strong predictor of both mortality and stroke occurrence.[@B18][@B39] A previous comparison of very severe comorbidity with no comorbidity found ischemic stroke increased both the 30-day and 5-year mortality rates by approximately 2.5-fold.[@B18] Comorbidity is also an important factor in poststroke functional recovery.[@B40] Insufficient rehabilitation therapies and repeated hospitalization due to multiple comorbidities contribute to poor functional outcomes.[@B41] Poor functional recovery in patients with multiple comorbidities cause decreased physical activity and deconditioning,[@B42][@B43] which lead to arterial stiffness, increased atherosclerosis, and failure to control other stroke risk factors.[@B43][@B44] These processes were therefore considered to increase the probability of stroke recurrence.

Several limitations of the present study should be considered when interpreting its findings. We confirmed stroke recurrence after calling the patients themselves or their caregivers by telephone at each time point. Although the research assistants visited the homes of the patients after establishing phone contact, a limitation was the difficulty of determining recurrence if the patients or caregivers could not be reached by telephone. Furthermore, a larger number of recurrent stroke patients may be missed by our protocol compared with a methodology utilizing a nationwide stroke registry to identify recurrence. The functional data at discharge of the patients who were not followed up are summarized in [Supplementary Table 1](#S1){ref-type="supplementary-material"} (in the online-only Data Supplement). We thought that patients with greater functional impairment due to neurological deficits were more likely to be lost to follow-up, but there were no differences in functional status. We consider it most likely that these patients stopped participating in the research intentionally during the follow-up for personal reasons. The degree of compliance with the protocol of this study was not investigated, and so the factors influencing compliance should be analyzed in a future study. Although the 76 patients who were lost to follow-up within 1 year accounted for a small proportion of the overall population, their exclusion may have influenced the results. In addition, information on adherence to medications for secondary prevention and good health-related behaviors was not collected during the follow-up. In Korea, medication prescriptions for secondary prevention and educating about health-related behaviors are mainly the responsibility of neurologists. However, the researchers visiting the present patients received regular training about medications and habitual education. They also taught the patients to comply with taking their medications and follow their instructions for behavioral changes during every visit. However, the actual compliance with these activities was not investigated in this study.

In conclusion, moderate-to-severe functional impairment at the time of discharge requiring the help of others (especially for ambulation) and the severity of comorbidity in addition to age were confirmed to be independent risk factors for stroke recurrence within 1 year of onset in patients with NCIS. Additional treatments focused on the recovery of ambulatory function may be a good strategy for preventing stroke recurrence.
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###### Supplementary Table 1

Clinical characteristics and functional status assessed at discharge of the patients who were not followed up

![Patient selection flowchart.](jcn-15-54-g001){#F1}

![Differences in the recurrence-free survival according to the Kaplan-Meier analysis. Significant differences in recurrence-free survival rate were found for the mRS score (A), the FAC score at discharge (B), and the CCI (C). CCI: Charlson Comorbidity Index, FAC: Functional Ambulatory Category, mRS: modified Rankin Scale.](jcn-15-54-g002){#F2}

###### Clinical characteristics of the patients and HRs from the univariate Cox proportional-hazards regression analyses for stroke recurrence

![](jcn-15-54-i001)

                                                        Recurrence: yes (n=34, %)   Recurrence: no (n=534, %)   HR (95% CI)         *p*
  ----------------------------------------------------- --------------------------- --------------------------- ------------------- -----------
  Baseline characteristics                                                                                                          
   Age, years                                           70.3±13.0                   63.7±19.4                   1.04 (0.97--1.06)   0.016^\*^
   Sex, male                                            60                          58                          1.21 (0.67--1.82)   0.309
   BMI, kg/m^2^                                         23.1±3.1                    23.5±3.4                    0.96 (0.90--1.02)   0.209
   Marital status, married                              79                          78                          1.17 (0.45--2.02)   0.470
   Education, ≥high school                              48                          49                          1.00 (0.38--1.62)   0.992
   Family history                                       11                          9                           1.48 (0.98--2.12)   0.169
   Smoking                                              57                          53                          1.06 (0.82--1.35)   0.771
   Alcohol                                              65                          62                          1.11 (0.74--1.55)   0.582
   CCI, \>2                                             27                          15                          2.20 (1.30--3.24)   0.008^\*^
  Past medical history                                                                                                              
   Hypertension                                         61                          58                          1.05 (0.46--1.67)   0.781
   Diabetes mellitus                                    30                          29                          1.34 (0.40--2.33)   0.134
   Ischemic heart disease                               8                           7                           1.20 (0.52--1.73)   0.596
   Atrial fibrillation                                  8                           6                           1.80 (1.02--3.03)   0.060^\*^
   Hyperlipidemia                                       13                          10                          1.73 (1.12--2.88)   0.055^\*^
  Initial neurological deficits in the emergency room                                                                               
   NIHSS score                                          8.6±6.2                     9.5±6.9                     1.01 (0.74--1.52)   0.325
  Laboratory data on admission                                                                                                      
   Fasting glucose, mg/dL                               101±16                      104±18                      1.00 (0.89--1.11)   0.681
   Total cholesterol, mg/dL                             176±41                      178±44                      0.99 (0.95--1.05)   0.325
   LDL-C, mg/dL                                         105±32                      108±36                      1.00 (0.89--1.09)   0.483
   HDL-C, mg/dL                                         45±13                       46±17                       0.98 (0.90--1.06)   0.889
   Triglycerides, mg/dL                                 124±76                      121±78                      1.00 (0.88--1.12)   0.450
   Creatinine, mg/dL                                    0.9±0.6                     1.0±0.6                     0.94 (0.90--1.00)   0.699
   Homocysteine, µmol/L                                 10.7±17.5                   9.2±10.6                    1.01 (0.86--1.16)   0.812
  Stroke features                                                                                                                   
   Lesion side, left                                    50                          46                          0.83 (0.39--1.69)   0.296
   Location, brain stem                                 30                          30                          1.07 (0.68--1.52)   0.729
  Subtypes                                                                                                                          
   LAA                                                  81                          77                          2.19 (1.33--3.42)   0.028^\*^
   Small-vessel occlusion                               18                          21                          1.02 (0.60--1.45)   0.113
   Others                                               1                           2                                               
  Acute-phase therapies                                                                                                             
   IV tPA                                               5                           6                           0.85 (0.49--1.16)   0.712
   IA tPA                                               5                           4                           1.46 (0.68--2.32)   0.224
   IV heparin                                           9                           10                          1.18 (0.63--1.94)   0.328
   Antiplatelet                                         81                          80                          1.44 (1.02--1.82)   0.123
  Medications at discharge                                                                                                          
   Antiplatelet                                         71                          76                          0.84 (0.45--1.26)   0.443
   Anticoagulation                                      10                          10                          0.99 (0.82--1.19)   0.220
   Antihypertensive                                     47                          41                          1.26 (0.94--1.66)   0.199
   Antidiabetic                                         24                          19                          1.08 (0.79--1.28)   0.748
   Antilipid                                            73                          68                          1.20 (0.93--1.63)   0.347

Noncategoric data are expressed as mean±SD values. Categoric data are expressed as percentage values.

^\*^*p*\<0.10.

BMI: body mass index, CCI: Charlson Comorbidity Index, CI: confidence interval, HDL-C: high-density lipoprotein cholesterol, HR: hazard ratio, IA: intra-arterial, IV: intravenous, LAA: large-artery atherosclerosis, LDL-C: low-density lipoprotein cholesterol, NIHSS: National Institutes of Health Stroke Scale, tPA: tissue plasminogen activator.

###### Functional status assessed at discharge and the results of the univariate Cox proportional-hazards regression analysis
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  Functional indicator        Recurrence: yes (n=34, %)   Recurrence: no (n=534, %)   HR (95% CI)         *p*
  --------------------------- --------------------------- --------------------------- ------------------- -------------
  mRS score, ≥3               42                          35                          1.85 (1.28--2.54)   0.010^\*^
  FAC score, ≤3               47                          34                          3.89 (2.32--5.65)   \<0.001^\*^
  FMA motor score, 0--79      48                          42                          1.46 (1.02-1.90)    0.048^\*^
  FIM, 18--90                 50                          46                          1.34 (0.94--1.74)   0.126
  K-MMSE score, 0--23         49                          51                          1.12 (0.86--1.40)   0.233
  K-FAST score                6.1±1.7                     6.2±1.6                     1.04 (0.80--1.28)   0.421
  ASHA-NOMS score, ≤6         32                          29                          0.78 (0.29--1.33)   0.250
  GDS-SF score                2.6±1.6                     2.2±1.5                     0.99 (0.80--1.19)   0.407
  EQ-5D score                 0.65±0.37                   0.60±0.35                   1.01 (0.98--1.04)   0.207
  Period to discharge, days   34.8±6.8                    34.2±7.0                    0.93 (0.84--1.04)   0.124

Noncategoric data are expressed as mean±SD values. Categoric data are expressed as percentage values.

^\*^*p*\<0.10.

ASHA-NOMS: American Speech-Language-Hearing Association National Outcome Measurement System Swallowing Scale, CI: confidence interval, EQ-5D: EuroQoL-5 Dimensions, FAC: Functional Ambulation Category, FIM: Functional Independence Measure, FMA: Fugl-Meyer Assessment, GDS-SF: Geriatric Depression Scale-Short Form, HR: hazard ratio, K-FAST: Korean version of the Frenchay Aphasia Screening Test, K-MMSE: Korean version of the Mini Mental State Examination, mRS: modified Rankin Scale.

###### Results of multivariate Cox proportional-hazards regression analyses for stroke recurrence
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                                      HR     95% CI       *p*
  ----------------------------------- ------ ------------ -----------
  Age                                 1.04   0.97--1.06   0.048^\*^
  Sex, male                           1.08   0.87--1.30   0.374
  NIHSS score in the emergency room   1.01   0.84--1.18   0.538
  CCI, \>2                            1.72   1.26--2.22   0.016^\*^
  LAA                                 1.23   1.06--1.59   0.082
  mRS score at discharge, ≥3          1.56   1.22--1.94   0.032^\*^
  FAC score at discharge, ≤3          2.56   1.84--3.31   0.008^\*^

^\*^*p*\<0.05.

CCI: Charlson Comorbidity Index, CI: confidence interval, FAC: Functional Ambulation Category, HR: hazard ratio, LAA: large-artery atherosclerosis, mRS: modified Rankin Scale, NIHSS: National Institutes of Health Stroke Scale.
